Latest News of BIOSU
Aroa Biosurgery Limited (ASX:ARX): Is Breakeven Near?
Aroa Biosurgery Limited is close to achieving profitability, expecting to break even in 2026. Analysts project a 56% annual growth rate until then. The company operates debt-free, reducing investment ...
Aroa Biosurgery And 2 Other ASX Penny Stocks To Watch
The Australian market saw a downturn, but interest remains in exploring penny stocks for growth potential. Aroa Biosurgery, Plenti Group, and Praemium are standout penny stock options with financial i...
We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn
Investors are often drawn to unprofitable companies with potential for growth. Aroa Biosurgery's cash burn rate is analyzed, showing a 2.1-year cash runway. Despite increasing cash burn, positive reve...